Tofa analogues, sebum reduction preparations containing said type of analogues and the cosmetic and / or therapeutic use of said type of analogues as an effective principle for reducing or preventing sebum
Patent Information
- Application Number
- EP2023701011
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-02-08
- Filing Date
- 2023-01-16
- Publication Date
- 2024-11-20
AI Technical Summary
Existing treatments for greasy hair and impure skin, including mild forms of acne, are inadequate in effectively reducing sebum production and addressing the underlying hormonal and sebaceous gland-related issues, leading to persistent greasiness and aesthetic concerns.
Development of new compounds, specifically TOFA analogues with specific hydroxyl group substitutions, are used in topical preparations to reduce sebum production in human skin, effectively treating greasy hair, impure skin, and mild forms of acne by targeting the sebaceous glands on the scalp and face.
The TOFA analogues in cosmetic and therapeutic preparations significantly reduce sebum production, providing long-lasting solutions for greasy hair and skin issues, improving hair and skin health by balancing sebaceous gland activity and addressing the root causes of seborrhea and acne.
Smart Images

Figure 1.1
Abstract
Description
[0001] Beiersdorf Aktiengesellschaft
[0002] Description
[0003] TOFA ANALOGUES, PREPARATIONS FOR SEBUM REDUCTION CONTAINING SUCH ANALOGUES AND THE COSMETIC AND / OR THERAPEUTIC USE OF SUCH ANALOGUES AS AN EFFECTIVE PRINCIPLE FOR SEBUM REDUCTION OR PREVENTION
[0004] The present invention relates to novel substances and their uses as active ingredients and preparations containing such active ingredients which are effective against oily and / or impure skin, as well as mild forms of acne and / or oily hair.
[0005] Seborrhea is a genetically determined overactivity of the sebaceous glands. Both the scalp and facial skin appear oily. The composition of seborrheic sebum is different from normal sebum, and three stages of seborrhea are distinguished:
[0006] 1. Simple seborrhea: Mild cases, oily after 8 days.
[0007] 2. Oily seborrhea: Oily after just 2-3 days.
[0008] 3. Irreversible form: Seborrhea, in which the hair looks coated in grease after just one day.
[0009] Excessive sebaceous gland secretion can be triggered, among other things, by androgenetic disorders (male sex hormone imbalances) and has an aesthetic detrimental effect on the overall appearance of the hair. This disorder can also be the cause of hair loss. Seborrheic scalp disorders are a precursor in both cases. Autonomic dysfunction and improper hair care can further worsen the skin's appearance and hair condition. Even with seborrhea, the hair itself can be dry due to disruptions in keratin formation. Dry, damaged hair is often caused by external stress such as sun exposure or chemical treatments. Blow-drying with excessively hot air or improper care of damaged hair can lead to damage.
[0010] The causes of oily hair lie within the human body and are hormonally dependent. Each hair has its own sebaceous gland that produces oil (also called sebum or sebum). Sebum production is hormonally controlled, and depending on the hormonal sensitivity of the sebaceous gland, overproduction or underproduction can occur. The sebum itself has the function of keeping the scalp supple. It passes from the sebaceous gland to the scalp and only later to the hairline. There it is normally absorbed by the hair shaft and remains invisible. When sebum is overproduced, the hair shaft is no longer able to absorb it. It becomes visible as a greasy film on the hair. The result is stringy, greasy and shiny hair.
[0011] Because sebaceous gland production depends on hormone levels, the problem of oily hair cannot be completely solved, as the sebaceous glands constantly produce oil. Consistent care and high-quality hair care products are still the best way to combat oily hair.
[0012] Unfortunately, greasy hair has very annoying consequences. Hair becomes stringy again shortly after washing, and the style doesn't hold.
[0013] Contrary to popular belief, it's just a myth that washing your hair too often makes it greasy even faster. Mild shampoos for oily hair ensure that excess oil is removed. Your hair and scalp are sufficiently moisturized and balance the overproduction of sebaceous glands.
[0014] Oily hair and dandruff are among the most common hair problems. These abnormalities are caused by a dysfunction of the sebaceous glands. An overactive sebaceous gland is referred to as seborrhea. There are two forms: the oily form (seborrhoea oleosa) and the dry form (seborrhoea sicca).
[0015] Seborrhoea oleosa:
[0016] This is caused by an overactive sebaceous gland, in which the sebaceous glands produce too much, oily sebum. As a result, the skin develops a greasy shine, and the hair becomes greasy and stringy right down to the tips just two to three days after washing.
[0017] Seborrhoea sicca:
[0018] It is also caused by an overactive sebaceous gland, but the sebum is drier and has a firmer consistency. It combines with the epidermal flakes to form large, easily crushed sebum flakes. The scalp has a waxy sheen, the hair only produces oil at the roots, and the lengths and especially the ends are dry and even brittle. Treatment for seborrhea begins with regular and thorough shampooing with special shampoos, which can be done as often as needed. Washing should be combined with a massage of the connective tissue, as this promotes the emptying of the sebaceous glands, which delays the buildup of oil.
[0019] In the case of impure skin and mild forms of acne, in addition to increased sebum production, other factors such as secondary bacterial infections are also of etiological importance. One of the most important microorganisms associated with impure skin is Propionibacterium acnes.
[0020] However, impure skin and / or comedones impair the well-being of those affected, even in mild cases. Since practically every young person is affected by impure skin of some kind, many people need to remedy this condition. Since excessive sebum production is a key factor, in many cases, the use of sebum-reducing active ingredients can improve the skin's condition.
[0021] The object of the present invention was therefore to find preparations effective against oily and / or impure skin, mild forms of acne and oily hair.
[0022] The state of the art already includes some attempts to solve this problem, but they do not fully recognize the advantages of the development presented here.
[0023] WO 2011 / 005660 discloses analogues of 5-(tetradecyloxy)-2-furancarboxylic acid (TOFA) and their antiseborrhoeic activity.
[0024] The document WO 2018 / 022797 discloses analogues of 5-(tetradecyloxy)-2-furancarboxylic acid (TOFA) and their effect against acne vulgaris.
[0025] The document WO 2019 / 115405 discloses analogues of pyrrole derivatives and their antiseborrhoeic effect.
[0026] However, it was surprisingly found, and therein lies the solution to the problem, that new compounds of the general formula (1) where R = n-tetradecyl, and R 1 , R 2 and R 3independently of one another represent -H, a hydroxyl group, a -C1-C24 alkyl substituted with one or more hydroxyl groups, with the proviso that at most two of the groups R 1 , R 2 and R 3 represent an H atom or a hydroxyl group, as well as medical or cosmetic topical preparations containing one or more such compounds in an effective concentration, as well as the cosmetic use of one or more such compounds for reducing sebum production in human skin, as well as the use of topical preparations containing one or more such compounds for treating oily and / or impure skin and / or mild forms of acne and / or oily hair and / or oily scalp and / or seborrhoea, remedy the disadvantages of the prior art.
[0027] The uses according to the invention follow a similar principle, since the sebaceous glands on the scalp and on the face are identically structured, and sebum production follows the same mechanism. Thus, by applying the sebum-reducing active ingredients to the scalp region, sebum production can be reduced, thus preventing the cosmetically undesirable condition of greasy hair.
[0028] According to the invention, preparations are particularly advantageous which are characterized in that one or more compounds of general formula (1), advantageously in a water and / or oil phase, are present in concentrations of 0.0001-40.00 wt.%, preferably 0.005-20.00 wt.%, particularly preferably 0.001-6.00 wt.%, in each case based on the total weight of the composition. Preferred compounds of formula (1) are:
[0029] Compound 3 (TOFA)
[0030] To a suspension of alcohol (2) (25.3 g, 117.8 mM) in 400 mL of o-xylene, NaH (60% in mineral oil, 7.85 g, 196.3 mM) was added at ambient temperature, and the mixture was stirred under reflux for 2 h. The mixture was cooled to approximately 70 °C, and acid (1) was added as a solid in one portion (15.0 g, 78.5 mM). The mixture was stirred under reflux for 48 h and cooled to ambient temperature. The mixture was quenched with aqueous KHSO4, extracted with EtOAc, and the organic layer was additionally washed with H2O, dried with Na2SO4, and evaporated. The residue was triturated with hexane to afford compound (3) (7.1 g, 28%). The synthesis was repeated several times to obtain the required amount of TOFA (approximately 100 g). ZE33-0116 (T113e)
[0031] Connection (63)
[0032] To a solution of TOFA (3) (13.1 g, 40 mM) in 500 mL of CH2Cl2 was added glycidol (62) (3.78 g, 51 mM), followed by the addition of EDCI (10.5 g, 55 mM) and DMAP (0.97 g, 8 mM), and the mixture was stirred at ambient temperature for 20 h. The solvent was evaporated, the residue was redissolved in EtOAc, washed with H2O, dried over Na2SO4, and evaporated. The residue was purified by column chromatography on silica gel, eluting with 15% EtOAc in hexane, to afford compound (63) (9.43 g, 61%).
[0033] Connection (64)
[0034] To a solution of 9.43 g (25 mM) of compound (63) in 120 mL of CH2Cl2 was added trifluoroacetic anhydride (26.4 g, 126 mM) in 40 mL of CF^CH at -30°C. The mixture was stirred for 4 h at ambient temperature and evaporated; the residue was co-evaporated with CCl4 to give compound (64) (14.5 g, 99%).
[0035] Connection (65) (ZE33-0116)
[0036] A solution of pyridine (22 g) and MeOH (13 g) in 100 mL of CH2Cl2 was added dropwise to a solution of compound (64) (14.5 g, 25 mM) in 120 mL of CH2Cl2 at -55 °C. The mixture was stirred for 0.5 h at -30 °C and then for 3 h at ambient temperature. The mixture was evaporated, and the residue was washed with hexane to give compound (65) (ZE33-0116) (9.85 g, 100%). ZE33-0117 (T74e)
[0037] Connection (67)
[0038] Protected glycerol (66) (4.1 g, 31 mM) was added to a solution of TOFA (3) (7.9 g, 24 mM) in 500 mL of CH2Cl2, followed by the addition of EDCI (6.3 g, 33 mM) and DMAP (0.61 g, 5 mM), and the mixture was stirred at ambient temperature for 20 h. The solvent was evaporated, the residue was redissolved in EtOAc, washed with H2O, dried over Na2SO4, and evaporated. The residue was purified by column chromatography on silica gel, eluting with 15% EtOAc in hexane, to afford compound (67) (9.16 g, 86%).
[0039] Connection (68) (ZE33-0117)
[0040] To a solution of compound (67) (8.78 g, 20 mM) in 400 mL of MeOH, 0.4 mL of 3 M HCl in dioxane was added, and the mixture was stirred at ambient temperature for 0.5 h. The mixture was evaporated and then co-evaporated with MeOH to a volume of approximately 20 mL. The resulting pellet was filtered off and dried to give compound (68) (ZE33-0117) (6.9 g, 87%).
[0041] The compounds according to the invention can advantageously be incorporated into cosmetic or dermatological preparations.
[0042] The preparations or uses according to the invention can be in the form of liquid compositions that can be applied by brush or wiper, roll-on devices, or sprayers, as sticks, and in the form of systems that can be applied from normal bottles and containers, e.g., creams, gels, or lotions. For example, they can be used in the following ways: B. a solution, an emulsion of the water-in-oil (W / O) or oil-in-water (O / W) type, or a multiple emulsion, for example of the water-in-oil-in-water (W / O / W), oil-in-water-in-oil (O / W / O) type, a gel, a hydrodispersion, a lamellar phase, a liquid isotropic solution phase, a micellar phase, a solid or dispersed mono- or polyhexanol phase, a solid or dispersed mono- or polycubic phase, a lyotropic phase, a crystalline phase, a solid stick or even an aerosol.
[0043] Furthermore, the preparations or uses according to the invention can advantageously be in the form of facial toners, tinctures, cleansing formulations, pads, cotton balls or wipes as well as in the form of tonics or shampoos.
[0044] Advantageously, the pH of the preparations or uses according to the invention is set in the weakly acidic to neutral range, preferably from 3.0 to 7.0, particularly preferably from 5.0 to 6.5.
[0045] The formulations according to the invention can be composed as usual and used for the treatment of skin and / or hair as a dermatological treatment or as a cosmetic treatment. However, they can also be used in make-up products, decorative cosmetics, or in cosmetic and dermatological cleansing products.
[0046] It is of course known to the person skilled in the art that cosmetic preparations are generally not conceivable without the usual auxiliary substances and additives.The cosmetic and dermatological preparations according to the invention may accordingly further contain cosmetic auxiliaries as are customarily used in such preparations; for example, consistency regulators, preservatives, stabilizers, fillers, perfumes, pigments having a coloring effect, thickeners, suspending agents, buffer mixtures, surface-active substances, emulsifiers, softening, moisturizing and / or humectant substances, anti-inflammatory substances, additional active ingredients such as vitamins or proteins, light stabilizers, insect repellents, bactericides, water, salts, antimicrobial, proteolytic or keratolytic substances, medicaments or other customary components of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, organic solvents or electrolytes.
[0047] The amounts of carriers to be used can be easily determined by a person skilled in the art by simple trial and error, depending on the type of product in question. Typical carriers for the preparation of the preparations or uses according to the invention include, in addition to water, ethanol, isopropanol, glycerin, and propylene glycol, skin-care fatty or fat-like substances such as decyl oleate, cetyl alcohol, cetylstearyl alcohol, and 2-octyldodecanol, in the proportions customary for such preparations, as well as mucilaginous substances and thickeners, e.g., hydroxyethyl or hydroxypropyl cellulose, polyacrylic acid, polyvinylpyrrolidone, and also, in small amounts, cyclic silicone oils (polydimethylsiloxanes) and liquid, low-viscosity polymethylphenylsiloxanes.
[0048] Non-ionic types such as polyoxyethylene fatty alcohol ethers, e.g. cetostearyl alcohol polyethylene glycol ethers with 12 or 20 attached ethylene oxide units per molecule, cetostearyl alcohol, as well as sorbitan esters and sorbitan ester-ethylene oxide compounds (e.g. sorbitan monostearate and polyoxyethylene sorbitan monostearate), and long-chain, higher molecular weight, waxy polyglycol ethers have proven suitable as emulsifiers for producing the preparations or uses according to the invention, which are advantageously to be applied as liquid or solid preparations to the desired skin areas and which can be used in the preparations in small amounts, e.g. 1 to 6 wt. %, based on the total composition. In addition, a whole range of other emulsifiers or emulsifier mixtures which are commonly used in cosmetic preparations are also suitable.These include, but are not limited to, glyceryl stearate citrate, PEG-40 stearate or polyglyceryl(3) methylglucose distearate, stearic acid, steareth-2 and steareth-21.
[0049] The oil phase of the preparations according to the invention is advantageously selected from the group of esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids with a chain length of 3 to 30 C atoms and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 C atoms, from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 C atoms.
[0050] Furthermore, the oil phase can advantageously be selected from the group of branched and unbranched hydrocarbons and waxes, silicone oils, dialkyl ethers, saturated or unsaturated, branched or unbranched alcohols, and fatty acid triglycerides, namely triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids with a chain length of 8 to 24, in particular 12-18, carbon atoms. The compounds of the oil phase can be of synthetic, semi-synthetic, or natural origin.
[0051] Any mixtures of such oil and wax components can also be used advantageously within the meaning of the present invention.
[0052] Advantageously, the content of the oil phase is between 1 and 50 wt.%, based on the total weight of the preparations, preferably 2 - 30 wt.%, particularly preferably less than 10 wt.%.
[0053] For use, the cosmetic and / or dermatological formulations according to the invention are applied to the skin, scalp and / or hair in sufficient quantities in the manner customary for cosmetics and dermatologicals.
[0054] Lipid assay for testing the efficacy of TOFA derivatives according to the invention
[0055] To determine the lipid-reducing effect of active substances, primary cell lines from sebaceous glands of various human donors are used. The cells are cultured for a total of 7 days. After the cells are seeded on day 1, the drug treatment takes place on days 3 and 5. On day 7, the cells are stained with the dye AdipoRed. This allows the lipid droplets inside the cells to be fluorescently stained and quantified. To monitor cell viability, the dye fluorescein diacetate (FDA), which is converted by living cells, is also used. The resulting fluorescence signal can also be quantified. The effect of an active substance can be measured and displayed as the ratio of the AdipoRed and FDA fluorescence signal relative to the ratio of the corresponding solvent.The tested substances were dissolved in dimethyl sulfoxide (DMSO), accordingly all results were normalized to the DMSO-treated control.
[0056] The following examples are intended to illustrate the invention but not to limit it. The figures are in wt. % unless otherwise stated.
[0057]
Claims
Patent claims Compounds of the general formula (1) where R = n-tetradecyl, and R 1 , R 2 and R 3 independently of each other, -H means a hydroxyl group, a -C1-C24 alkyl substituted with one or more hydroxyl groups, with the proviso that at most two of the groups R 1 , R 2 and R 3 representing a hydrogen atom or a hydroxyl group. Compounds according to claim 1, characterized in that they are selected from the group Medicinal or cosmetic topical preparations containing one or more compounds of formula (1) according to claim 1 or 2 in an effective concentration, Medicinal or cosmetic topical preparations containing one or more compounds of formula (1) according to claim 1 or 2 in concentrations of 0.0001 - 40.00 wt.%, preferably 0.005 - 20.00 wt.%, particularly preferably 0.001 - 6.00 wt.%, in each case based on the total weight of the composition. Cosmetic use of one or more compounds of formula (1) according to Claim 1 or 2 for reducing sebum production in human skin, One or more compounds of formula (1) according to claim 1 or 2 for the therapeutic treatment of oily and / or impure skin and / or mild forms of acne and / or oily hair and / or oily scalp and / or seborrhea.
